• Privacy Policy
  • Terms & Conditions
Top Stocks Insider
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Top Stocks Insider
No Result
View All Result
Home News

Bob Murphy vs. Dave Smith on the Johns Hopkins Lockdown Study

by
February 22, 2022
in News
0
0
SHARES
30
VIEWS
Share on FacebookShare on Twitter

Bob explains the friendly exchange he had with Dave Smith regarding the new Johns Hopkins study that concluded lockdowns did little to reduce mortality. Smith had tweeted that in a sane world, all those favoring lockdowns would be publicly disgraced, while Bob argues that these studies are so open-ended that people on both sides can reasonably ignore those that disagree with their preferred conclusions.

Mentioned in the Episode and Other Links of Interest:

Dave Smith’s original tweet about the Johns Hopkins studyBob’s article on Nordhaus vs. the UNA Reuters “fact check” that cites Johns Hopkins experts on why lockdowns DO workA Politifact pushback on Johns Hopkins study

​For more information, see BobMurphyShow.com. The Bob Murphy Show is also available on Apple Podcasts, Google Podcasts, Stitcher, Spotify, and via RSS.

 

Previous Post

Capital versus Labor: The Great Decoupling

Next Post

Böhm-Bawerk’s Critique of the Exploitation Theory of Interest

Next Post

Böhm-Bawerk’s Critique of the Exploitation Theory of Interest

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Disclaimer: TopStocksInsider.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2024 TopStocksInsider. All Rights Reserved.

    No Result
    View All Result
    • News
    • Economy
    • Editor’s Pick
    • Investing
    • Stock

    Copyright © 2024 TopStocksInsider. All Rights Reserved.